Another in vivo study [32] showed that MSCs genetically engineered to express WNT4 could enhance osteogenesis and improve the repair of craniofacial defects in two different models of craniofacial bone injury, suggesting that WNT4 protein may prove to be a potential target for osteoporosis treatment. Here, WNT4 is linked to osteoporosis.